Param Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.55 M
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 60.27%
- Ebitda 87.15%
- Net Worth 6.31%
- Total Assets 3423.17%
About Param Life Sciences
Param Life Sciences Private Limited (PLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 1989 and has a history of 36 years and one month. Its registered office is in Delhi, India.
The Corporate was formerly known as S, .S. Tranship Comsultants Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.55 M, as per Ministry of Corporate Affairs (MCA) records.
Mohak Rai and Manan Mittal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1989PTC034515
- Company No.
034515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Param Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohak Rai  | Director | 01-Dec-2008 | Current |
| Manan Mittal | Director | 20-Dec-2008 | Current |
Financial Performance of Param Life Sciences.
Param Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 60.27% increase in profit. The company's net worth moved up by a moderate rise of 6.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Param Life Sciences?
In 2021, Param Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Embee Healthcare Private LimitedMohak Rai and Manan Mittal are mutual person
- Embee Diagnostics Private Limited
Mohak Rai and Manan Mittal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Param Life Sciences?
Unlock and access historical data on people associated with Param Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Param Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Param Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
